Inhibition of human pancreatic islet insulin release by receptor-selective somatostatin analogs directed to somatostatin receptor subtype 5

Biochemical Pharmacology

Volumn 57, Issue 10, 1999, Pages 1159-1164

  Zambre, Yasmeen ^a   Ling, Zhidong ^a   Chen, Meng Chi ^a   Hou, Xue ^a   Woon, Chee Wai ^b   Culler, Michael ^b   Taylor, John E ^b   Coy, David H ^c   Van Schravendijk, Chris ^a   Schuit, Frans ^a   Pipeleers, Daniel G ^a   Eizirik, D écio L ^c  

^a DIABETES RESEARCH CENTER   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c TULANE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Insulin release; Pancreatic islets; Somatostatin; Somatostatin analogs; Somatostatin receptor

Indexed keywords

ANGIOPEPTIN; BIM 23023; BIM 23190; BIM 23197; BIM 23268; BIM 23313; GLUCOSE; INSULIN; MESSENGER RNA; RECEPTOR SUBTYPE; SOMATOSTATIN 14; SOMATOSTATIN 28; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INSULIN RELEASE; ISOLATED PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMYLOID; HUMANS; INSULIN; ISLETS OF LANGERHANS; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PEPTIDES, CYCLIC; PIPERAZINES; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; SOMATOSTATIN-28; SOMATOSTATIN-SECRETING CELLS;

EID: 0033562492     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00010-6     Document Type: Article

References (26)

1. Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science. 179:1973;77-79.
2. Reichlin S. Somatostatin. N Engl J Med. 309:1983;1495-1563.
3. Benoit R., Bohlen P., Brazeau P., Ling N., Guillemin R. Isolation and characterization of rat pancreatic somatostatin. Endocrinology. 107:1980;2127-2129.
4. Koerker D.J., Ruch W., Chideckel E., Palmer J., Goodner C.J., Ensinck J., Gale C.C. Somatostatin Hypothalamic inhibitor of the endocrine pancreas . Science. 184:1974;482-483.
5. Mandarino L., Stenner D., Blanchard W., Nissen S., Gerich J., Ling N., Brazeau P., Bohlen P., Esch F., Guillemin R. Selective effects of somatostatin-14, -25 and -28 on in vitro insulin and glucagon secretion. Nature. 291:1981;76-77.
6. Schuit F.C., Derde M.P., Pipeleers D.G. Sensitivity of rat pancreatic A and B cells to somatostatin. Diabetologia. 32:1989;207-212.
7. Lamberts S.W., Krenning E.P., Reubi J.-C. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev. 12:1991;450-482.
8. 65 in human pancreatic islets. J Clin Endocrinol Metab. 75:1992;1574-1576.
9. Coy D.H., Rossowski W.J. Somatostatin analogs and multiple receptors Possible physiological roles . Ciba Found Symp. 190:1995;240-254.
10. Reisine T., Bell G.I. Molecular biology of somatostatin receptors. Endocr Rev. 16:1995;427-442.
11. Yamada Y., Post S.R., Wang K., Tager H.S., Bell G.I., Seino S. Cloning and functional characterisation of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract and kidney. Proc Natl Acad Sci USA. 89:1992;251-255.
12. Yasuda K., Rens-Domiano S., Breder C.D., Law S.F., Saper C.B., Reisine T., Bell G.I. Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylyl cyclase. J Biol Chem. 267:1992;20422-20428.
13. Bruno J.F., Xu Y., Song J.F., Berelowitz M. Molecular cloning and functional expression of a brain-specific somatostatin receptor. Proc Natl Acad Sci USA. 89:1992;11151-11155.
14. O'Carrol A.-M., Lolait S.J., Konig M., Mahan L.C. Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28. Mol Pharmacol. 42:1992;939-946.
15. Shimon I., Taylor J.E., Dong J.Z., Bitonte R.A., Kim S., Morgan B., Coy D.H., Culler M.D., Melmed S. Somatostatin receptor subtype specificity in human fetal pituitary cultures-Differential role of SSTR2 and SSTR5 for growth hormone, thyroid stimulating hormone, and prolactin regulation. J Clin Invest. 99:1997;789-798.
16. Rossowski W.J., Coy D.H. Specific inhibition of rat pancreatic insulin or glucagon release by receptor-selective somatostatin analogs. Biochem Biophys Res Comm. 205:1994;341-346.
17. Hunyady B., Hipkin R.W., Schonbrunn A., Mezey E. Immunohistochemical localization of somatostatin receptor SST2A in the rat pancreas. Endocrinology. 138:1997;2632-2635.
18. Moldovan S., Atiya A., Adrian T.E., Kleinman R.M., Lloyd K., Olthoff K., Imagawa D., Shevlin L., Coy D., Walsh J., Brunicardi F.C. Somatostatin inhibits B-cell secretion via a subtype-2 somatostatin receptor in the isolated perfused human pancreas. J Surg Res. 59:1995;85-90.
19. Kubota A., Yamada Y., Kagimoto S., Shimatsu A., Imamura M., Tsuda K., Imura H., Seino S., Seino Y. Identification of somatostatin receptor subtype and an implication of the efficacy of somatostatin analog SMS 201-995 in treatment of human endocrine tumors. J Clin Invest. 93:1994;1321-1325.
20. Keymeulen B., Ling Z., Gorus F.K., Delvaux G., Bouwens L., Grupping A., Hendrieckx C., Pipeleers-Marichal M., Van Schravendijk C., Salmela K., Pipeleers D.G. Implantation of standardized beta-cell grafts in a liver segment of IDDM patients Graft and recipient characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft . Diabetologia. 41:1998;452-459.
21. Ling Z., Pipeleers D. Prolonged exposure of human B cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation. J Clin Invest. 98:1996;2805-2812.
22. Pipeleers D.G., In't Veld P.A., van de Winkel M., Maes E., Schuit F., Gepts W. A new in vitro model for the study of pancreatic A and B cells. Endocrinology. 117:1985;806-816.
23. Pavlovic D., van de Winkel M., van der Awera B., Chen M.-C., Schuit F., Bowens L., Pipeleers D. Effect of interferon-γ and glucose on major histocompatibility complex class I and class II expression by pancreatic B and non-B cells. J Clin Endocrin Metab. 82:1997;2329-2336.
24. Lefebvre V.H., Otonkoski T., Ustinov J., Huotari M.-A., Pipeleers D.G., Bowens L. Culture of adult human islet preparations with hepatocyte growth factor and 804G matrix is mitogenic for duct cells but not for β cells. Diabetes. 47:1998;134-137.
25. Kellogg D.E., Rybalkin I., Chen S., Mukhamedova N., Vlasik T., Siebert P.D., Chenchik A. TaqStart antibody "Hot start" PCR followed by a neutralizing monoclonal antibody directed against Taq DNA polymerase . Biotechniques. 16:1994;1134-1137.
26. Björk E., Berne C., Karlsson F.A. Induction of β-cell rest in type 1 diabetes. Studies on the effects of octreotide and diazoxide. Diabetes Care. 21:1998;427-430.